* CareDx Inc CDNA.OQ reported a quarterly adjusted loss
of 7
cents per share for the quarter ended in December. The mean
expectation of seven analysts for the quarter was for a loss
of 9 cents per share.
* Revenue rose 4% to $82.38 million from a year ago;
analysts
expected $81.66 million.
* CareDx Inc's reported EPS for the quarter was a loss of 34
cents.
* The mean earnings estimate of analysts had risen by
about 2% in
the last three months.
* In the last 30 days one analyst negatively revised an
earnings
estimate
* CareDx Inc shares had risen by 26.6% this quarter.
* The company reported a quarterly loss of $18.24 million.
* Wall Street's median 12-month price target for CareDx Inc
is
$26.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data February
27 at 10:02 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.09 -0.07 Beat
Sep. 30 2022 -0.14 -0.06 Beat
Jun. 30 2022 -0.11 -0.13 Missed
Mar. 31 2022 -0.05 -0.13 Missed